2021-08-23 20:47:30
يسعد مساكم
#GIT_24 #IBD
Drug Used in Inflammatory Bowel Disease Treatment
في عنا اربع مجموعات دوائيه بنستخدمها في علاج ال IBD ...
Drug with 5 aminosalicylic acid
Corticosteroids
Immunomodulators
Biologic Agent
بشكل عام الادويه اللي بتعالج IBD بيكون استخدامها حاجه من الاتنين :
Induction Therapy
And/OR
maintenance Therapy
ال Induction لعلاج ال Active Episode of IBD
اما ال Maintenance لمنع ال Relaps
اول مجموعه واقدم مجموعه تم اكتشافها لعلاج ال IBD هي الادويه اللي بتحتوي على مركب ال 5aminosalicylic acid
وبتستخدم لل Induction وال Maintenance
في عنا مجموعتين للادويه اللي بتحتوي على ال 5Aminosalicylic acid :
Azo Compounds Mesalamine
اول مجموعه هي ال Azo compound
بتحتوي على ال 5Aminosalicylic acid مرتبط مع مركب آخر
فهي عباره عنProdrug ومن أمثلتها
Sulfasalazine
( 5Aminosalicylic acid + Sulfapyridin )
Oral: Tablets should be administered in evenly divided doses, preferably after meals. Delayed-release tablets should be swallowed whole.
Dose :
4-6 gram/day for Induction
2-4 gram /day for maintenance
Other Guideline for Sulfasalazine doses
Initial: 3 to 4 g/day in divided doses at ≤8-hour intervals; may initiate therapy with 1 to 2 g/day to reduce GI intolerance. Doses >4 g/day can increase the risk of toxicity.
Maintenance dose: 2 g/day in divided doses at ≤8-hour intervals when endoscopic exam confirms improvement
Dosage adjustment: If GI intolerance occurs, reduce dosage by 50% and gradually increase to target dose over several days. If GI intolerance persists, stop therapy for 5 to 7 days and reintroduce at a lower daily dose.
Crohn disease (mild to moderately active) (off-label use): Oral: 3 to 6 g/day in divided doses for up to 16 weeks
Balsalazide
( 5-aminosalicylic acid +4-aminobenzoyl-beta-alanine )
May administer with or without food. Maintain adequate hydration during therapy (to minimize nephrolithiasis risk).
Dose
Ulcerative colitis, remission induction: Oral:
Capsule: 2.25 g 3 times daily for 8 to 12 weeks.
Tablet: Males: 3.3 g twice daily for up to 8 weeks.
Ulcerative colitis, remission maintenance (off-label use): Capsule: 1.5 or 3 g twice daily for 6 to 12 months
Olsalazine
Administer with food in evenly divided doses. Maintain adequate hydration during therapy (to minimize nephrolithiasis risk).
Dose
Ulcerative colitis, remission maintenance: Oral: 1 g/day in 2 divided doses.
Ulcerative colitis, remission induction (off-label use): Oral: 2 to 3 g/day in 2 to 4 divided doses
ال Azo compound كلها prodrug بمجرد وصولها ال Intestine بيصيرلها Cleavage وبتحرر لل Active compound
5Aminosalicylic acid ( 5-ASA)
mechanism of action of 5-ASA is unknown; however, it is thought that it modulates local chemical mediators of the inflammatory response, especially leukotrienes, and is also postulated to be a free radical scavenger or an inhibitor of tumor necrosis factor (TNF); action appears topical rather than systemic
أشهر SE لل Azo compound خصوصا ال Sulfasalazine
Dose-related adverse effects (due to the sulfapyridine portion): GI disturbance, headache, arthralgia, folate malabsorption
فبننصح المريض ياخد folic acid supplement
Idiosyncratic adverse effects: rash, fever, pneumonitis, hepatotoxicity, bone marrow suppression, hemolytic anemia, pancreatitis, decreased sperm production in men
So CBC should be done 3-6 month of therapy
Serum creatinine should be monitored in Renal fauiler pateint
Avoid in patients with a sulfa allergy.
البوست القادم ان شاء الله رح نكمل مع تاني مجموعه بتحتوي على ال 5Aminosalicylic acid اللي هي ال Mesalamine
#لعلي_أفيدك
1.3K viewsHadeeL, 17:47